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ABSTRACT
Bariatric surgery, such as vertical sleeve gastrectomy (VSG), causes
remarkable improvements in cardiometabolic health, including
hypertension remission. However, the mechanisms responsible
remain undefined and poorly studied. Therefore, we developed and
validated the first murine model of VSG that recapitulates the blood
pressure-lowering effect of VSG using gold-standard radiotelemetry
technology. We used this model to investigate several potential
mechanisms, including bodymass, brain endoplasmic reticulum (ER)
stress signaling and brain inflammatory signaling, which are all critical
contributors to the pathogenesis of obesity-associated hypertension.
Mice fed on a high-fat diet underwent sham or VSG surgery and
radiotelemeter implantation. Sham mice were fed ad libitum or were
food restricted to match their body mass to VSG-operated mice
to determine the role of body mass in the ability of VSG to lower
blood pressure. Blood pressure was then measured in freely moving
unstressed mice by radiotelemetry. VSG decreased energy intake,
body mass and fat mass. Mean arterial blood pressure (MAP) was
reduced in VSG-operated mice compared with both sham-operated
groups. VSG-induced reductions in MAP were accompanied by a
body mass-independent decrease in hypothalamic ER stress,
hypothalamic inflammation and sympathetic nervous system tone.
Assessment of gut microbial populations revealed VSG-induced
increases in the relative abundance of Gammaproteobacteria and
Enterococcus, and decreases inAdlercreutzia. These results suggest
that VSG reduces blood pressure, but this is only partly due to the
reduction in body weight. VSG-induced reductions in blood pressure
may be driven by a decrease in hypothalamic ER stress and
inflammatory signaling, and shifts in gut microbial populations.
KEYWORDS: Vertical sleeve gastrectomy, Hypertension, ER stress,
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INTRODUCTION
Bariatric surgery is currently the most effective long-term treatment
for obesity and results in high rates of remission for type 2 diabetes
and hypertension (Buchwald et al., 2004; Flores et al., 2014; Tritsch
et al., 2015). Furthermore, bariatric surgery produces a greater
reduction in arterial blood pressure (AP) than medical management
alone (Halperin et al., 2014). However, the mechanisms by which
this occurs remain elusive. While the mechanisms mediating the
improvement in glucose homeostasis after bariatric surgery are
being studied extensively, surprisingly few preclinical studies have
been conducted to improve our understanding of how bariatric
surgery causes hypertension remission.
Vertical sleeve gastrectomy (VSG) has gained popularity as a
bariatric procedure that produces weight loss and improves glucose
regulation and cardiovascular disease outcomes at rates similar to
Roux-en-Y gastric bypass (RYGB) and is currently one of the most
commonly performed bariatric procedures (Benaiges et al., 2011).
VSG involves removal of ∼70% of the stomach by transecting the
greater curvature of the stomach. In an effort to improve our
understanding of the mechanisms driving the cardiometabolic
benefits of bariatric surgery we have validated a mouse model of
VSG (McGavigan et al., 2015). Consistent with observations in
human patients, our murine VSG model exhibits decreased food
intake and bodymass, and bodymass-independent improvements in
glucose regulation (McGavigan et al., 2015). Therefore, we used our
murine VSG model to develop and validate a mouse model that
recapitulates the effect of VSG to reduce AP in humans. We then
used this model to investigate potential mechanisms by which VSG
surgery reduces AP.
Obesity is considered a major risk factor for the development of
hypertension. Therefore, loss of body mass after bariatric surgery
probably contributes to reduced AP. However, remission of type 2
diabetes and hypertension have been reported within days after
surgery, prior to significant body mass loss (Ahmed et al., 2009;
Pories et al., 1995). Thus, the human clinical literature suggests that
there are body mass-independent mechanisms contributing to
hypertension remission after bariatric surgery.
Two potential contributors to the body mass-independent effect
of bariatric surgery to reduce AP are reductions in brain ER-stress
signaling and shifts in gut microbial populations. ER-stress
signaling is elevated in obesity and plays an integral role in the
development of obesity-associated hypertension (Ozcan et al.,
2004; Purkayastha et al., 2011b; Young et al., 2012). ER stress
occurs when the folding capacity of the ER is exceeded and
misfolded proteins accumulate leading to initiation of the unfolded
protein response (UPR). The UPR is triggered by transmembrane
sensors that detect unfolded proteins in the ER. These proteins
are: PKR-like ER kinase (PERK), inositol-requiring enzyme 1α
(IRE1α) and activating transcription factor 6 (ATF6) (Ron and
Walter, 2007). The UPR is a highly evolutionarily conserved series
of signaling pathways that act to restore ER homeostasis. For
example, activation of PERK results in phosphorylation and
inactivation of eukaryotic translation inhibition factor 2α (eIF2α),
leading to decreased protein synthesis (Ron and Walter, 2007).Received 15 August 2016; Accepted 4 January 2017
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Work in rodent models demonstrates that enhanced ER-stress
signaling in brain areas, such as the hypothalamus, increases AP
(Purkayastha et al., 2011b). Conversely, restoration of brain ER
homeostasis markedly reduces AP (Young et al., 2012).
Alterations in gut microbial populations have been implicated in
the pathogenesis of various cardiometabolic diseases, including
hypertension (Turnbaugh et al., 2006; Yang et al., 2015).
Specifically, obese and lean phenotypes are transmissible via
inoculation of germ-free mice with obese or lean microbiomes
(Turnbaugh et al., 2006). Similarly, a hypertensive phenotype is
transmissible via inoculation of normotensive rats with a
hypertensive microbiome (Durgan et al., 2016). Furthermore,
previous work reports that transplantation of gut microbiota
derived from RYGB-operated mice or humans to gnotobiotic
mice produces metabolic improvements compared with control
transplants (Liou et al., 2013; Tremaroli et al., 2015). Therefore,
shifts in the gut microbiota may contribute to the cardiometabolic
benefits of bariatric surgery. Although shifts in gut microbe
populations after RYGB have been well-defined, few studies have
investigated the impact of VSG on gut microbiota.
Identification of the mechanisms by which bariatric surgery
reduces AP may reveal novel therapeutic strategies for hypertension
treatment. Validation of an appropriate preclinical model is critical
to take advantage of this opportunity to improve the care of patients
suffering from hypertension. Here, we validate the first murine
bariatric model that exhibits reductions in AP measured by gold-
standard radiotelemetry technology. We demonstrate that this effect
occurs, in part, independent of body mass. Finally, we present novel
data showing that VSG-induced reductions in AP are associated
with concurrent reductions in hypothalamic ER stress and
inflammation, and shifts in gut microbial populations.
RESULTS
VSG surgery decreases energy intake, body mass and
circulating leptin and ghrelin concentrations
Similar to our previous work (McGavigan et al., 2015), VSG
surgery reduced cumulative energy intake, body mass and fat
mass compared with sham-operated mice fed ad libitum (S-AL)
(Fig. 1A-C; P<0.05). Body mass and white adipose depot mass
(mesenteric, retroperitoneal, epididymal and subcutaneous) did not
differ between VSG and sham-operated weight-matched (S-WM)
controls (Fig. 1B,C). Therefore, we were able to assess the body
mass-independent effect of VSG surgery on AP. Similar to previous
studies in rats (Rodríguez et al., 2012a,b), heart mass did not
significantly differ between groups (Fig. 1D).
Leptin is an adipocyte-derived hormone that is often elevated
in obesity and has been shown to contribute to obesity-associated
increases in blood pressure (Simonds et al., 2014). As expected,
VSG surgery significantly reduced circulating leptin levels
compared with levels in S-AL mice at 2.5 months after surgery
(Fig. 2A; P<0.05). However, there was no difference in
circulating leptin concentrations between VSG and S-WM mice
(Fig. 2A). Ghrelin is an orexigenic hormone produced by
enteroendocrine cells located in the gastric mucosa that
promotes weight gain and insulin resistance (Sun et al., 2006).
Circulating ghrelin concentrations, which are decreased following
VSG in humans and rodent models, have been suggested to
contribute to the metabolic benefits of VSG surgery (Cummings
et al., 2012; Mans et al., 2015). Consistent with previous reports
(Cummings et al., 2012; Mans et al., 2015), our murine VSG
model exhibited decreased fasting plasma total ghrelin
concentrations compared with S-AL and S-WM controls
(Fig. 2B; P<0.05).
Fig. 1. VSG reduces body mass and
energy intake. The effect of VSG
surgery on cumulative energy intake
(A), body mass (B) white adipose
tissue depot mass (C) and heart mass
(D) in VSG-operated mice (VSG) and
sham-operated ad libitum-fed or
weight-matched mice (S-AL and
S-WM, respectively). *P<0.05,
compared with S-AL; +P<0.05,
compared with S-WM by two-factor
ANOVA for body mass and by
Student’s t-test for all other variables.
Data are expressed as mean±s.e.m.
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VSG surgery decreases AP
Mean arterial blood pressure (MAP) was reduced in S-WM relative
to S-AL mice during the light phase at 5 weeks after surgery
(Fig. 3A, P<0.05). In contrast, MAP was reduced in VSG-operated
mice compared with S-AL animals during the light and/or dark
phases during post-operative weeks 4-7 (Fig. 3A, P<0.05). MAP
was lower in VSG compared with S-WM during both the light and
dark cycles at 7 weeks after surgery, demonstrating a body mass-
independent effect of VSG surgery to reduce MAP (P<0.05). Of
note, body mass did not significantly differ between groups during
weeks 4-6, emphasizing the body mass-independent reduction in
MAP after VSG. A representative trace taken from week 7 after
surgery is shown in Fig. 3B. These reductions inMAP are consistent
with the human clinical literature which reports reductions of
5-10 mmHg in MAP after RYGB and VSG (Carson et al., 1994;
Hinojosa et al., 2009; Seravalle et al., 2014). Our VSGmodel is also
consistent with work done in a DIO rat model of VSG that reports
similar reductions in MAP compared with ad libitum-fed control
rats by tail-cuff plethysmography (Moncada et al., 2016; Rodríguez
et al., 2012a).
Both S-WM and VSG-operated groups exhibited significantly
lower systolic blood pressure compared with S-AL mice during the
light cycle in weeks 4-5 after surgery (Fig. 3C, P<0.05). However,
during weeks 6-7 after surgery, only VSG significantly lowered
systolic blood pressure compared with S-AL (P<0.05).
Furthermore, only VSG mice showed a significantly lowered
systolic blood pressure compared with S-AL animals during the
dark cycle, when activity levels and AP are highest (Fig. 3C,
P<0.05). Diastolic blood pressure and pulse pressure did not differ
between groups during the light cycle (Fig. 3D,E). However,
diastolic blood pressurewas decreased in VSG compared with S-AL
and S-WM mice at 7 weeks after surgery during the dark cycle
(Fig. 3D P<0.05). Heart rate did not differ between the groups
(Fig. 3F, P<0.05).
The impact of VSG on MAP and systolic blood pressure was
similar in the light and dark cycles, demonstrating that VSG-
induced improvements inMAPoccur independent of light cycle and
activity level. However, the effect of VSG to lower diastolic blood
pressure was only observed in the dark cycle, demonstrating that
VSG only decreases diastolic blood pressure when activity and AP
are high. This suggests that VSG-induced reductions inMAP during
the light cycle are primarily due to a lowering in systolic blood
pressure, whereas VSG-induced reductions in MAP during the dark
cycle are due to a combination of reduced systolic and diastolic
blood pressure. VSG-induced reductions in MAP, systolic blood
pressure and diastolic blood pressure could be due to reduced
sympathetic output, which has been observed after bariatric surgery
in human patients, and points to a neurogenic mechanism (Guyenet,
2006; Seravalle et al., 2014).
VSG reduces hypothalamic ER stress and inflammatory
signaling independent of body weight
It is well documented that obesity increases ER-stress signaling
(Ron and Harding, 2012). Elevated ER-stress signaling in brain
regions such as the hypothalamus and brainstem increases AP
(Chao et al., 2013; Purkayastha et al., 2011b). Furthermore, obesity
induced by a high-fat diet has been shown to elevate hypothalamic
ER stress and AP (Purkayastha et al., 2011b). Therefore, we
investigated the effect of VSG on all three pathways of ER-stress
signaling in the hypothalamus and brainstem. VSG surgery reduced
phosphorylation of hypothalamic PERK and its downstream
mediator, eIF2α, compared with S-AL and S-WM mice (Fig. 4A;
P<0.05). While IRE1α phosphorylation tended to be decreased
in VSG-operated mice, this did not reach significance. Cleaved
ATF6 protein expression did not differ between groups (Fig. 4A).
Therefore, VSG decreases hypothalamic PERK-mediated ER-stress
signaling independent of body mass.
All three ER-stress signaling pathways converge to activate
NF-κB and thereby promote production of inflammatory mediators,
such as TNFα. Hypothalamic inflammation has been implicated in
the pathogenesis of hypertension (Harrison et al., 2011), with
previous work reporting that an increase in hypothalamic TNFα
raises AP (Purkayastha et al., 2011a). Therefore, we measured
hypothalamic expression of TNFα and found a significant reduction
in VSG-operated animals compared with S-WM (Fig. 4A; P<0.05).
Although TNFα tended to be decreased after VSG compared with
levels in S-AL mice, this did not reach significance. VSG-induced
reductions in hypothalamic TNFα expression may be a result of
decreased ER stress signaling and may also contribute to post-
operative reductions in AP.
Interestingly, hypothalamic ER stress and inflammatory signaling
did not significantly differ between S-AL and S-WM groups
(Fig. 4A). Previous work has shown that obesity induced by
high-fat diets increases hypothalamic inflammation and ER stress
(Purkayastha et al., 2011a). However, we are not aware of a previous
study that has differentiated between the effect of diet and body
mass on hypothalamic ER stress and inflammatory signaling. Our
data suggest that a high-fat diet increases hypothalamic ER stress
and inflammation, which is at least partly independent of
body mass.
ER-stress signaling in the brainstem did not differ between
groups (Fig. 4B). TNFα was elevated in S-AL mice compared with
Fig. 2. VSG decreases fasting plasma leptin and ghrelin concentrations.
Fasting plasma leptin (A), and total ghrelin (B) concentrations at baseline and
at 2.5 months after surgery in VSG-operated mice (VSG) and sham-operated
ad libitum-fed or weight-matched mice (S-AL and S-WM, respectively).
*P<0.05, compared with S-AL; +P<0.05, compared with S-WM by two-factor
ANOVA. Data are expressed as mean±s.e.m.
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S-WM and VSG groups, but did not differ between S-WM andVSG
(Fig. 4B, P<0.05). These data suggest that increased body mass
increases inflammatory signaling in the brainstem. Interestingly,
inflammation in the brainstem has been implicated in the
pathogenesis of hypertension in non-obese spontaneously
hypertensive rats (Waki et al., 2011), suggesting that brainstem
inflammation may have contributed to elevated AP in S-AL mice.
Together, these data demonstrate that reductions in ER stress in the
brainstem do not contribute to VSG-induced decreases in AP.
Furthermore, these data demonstrate that the effect of VSG to lower
ER stress and inflammation is not found throughout the brain.
Reductions in hypothalamic ER stress and inflammatory
signaling have been shown to reduce AP by decreasing
sympathetic outflow (Chao et al., 2013; Purkayastha et al., 2011a,b).
Indeed, work in rodent models shows that increased ER stress and
inflammatory signaling in the hypothalamus increases AP and
sympathetic tone, and sympathetic suppression prevents the effect
of hypothalamic ER stress and inflammation to increase AP
(Purkayastha et al., 2011a,b). Furthermore, both RYGB and VSG
surgery are associated with a decrease in sympathetic tone in
humans (Curry et al., 2013; Seravalle et al., 2014), which has been
suggested to contribute to the AP-lowering effect of bariatric
surgery (Zhang et al., 2014). Therefore, we measured fasting plasma
norepinephrine (NE) concentrations as an indicator of sympathetic
activity. Consistent with the human clinical literature, VSG reduced
circulating NE concentrations compared with levels in S-AL and
S-WMmice (Fig. 4C, P<0.05). Therefore, VSG-induced reductions
in hypothalamic ER stress may decrease AP by decreasing
sympathetic tone.
VSG surgery produces shifts in gut microbial populations
Alterations in gut microbial populations have been suggested to
contribute to the benefits produced by bariatric surgery, including
VSG. The effect of bariatric surgery on the gut microbiome has been
primarily characterized after RYGB, with few studies investigating
the impact of VSG on gut microbial populations. Furthermore,
the gut microbiota has been implicated in the modulation of
brain inflammatory status (Wang and Kasper, 2014). Therefore, we
assessed the impact of VSG on gut microbial populations by 16S
rRNA gene sequencing. Principal coordinates analysis (PCoA) of
the weighted and unweighted UniFrac distances between samples
revealed differential clustering of VSG-operated mice compared
Fig. 3. VSG reduces mean arterial
blood pressure. (A) The effect of VSG
surgery onMAP. (B) Representative trace
of MAP during week 7 after surgery. The
effect of VSG surgery on systolic
pressure (C), diastolic pressure (D), pulse
pressure (E) and on heart rate (F). VSG,
VSG-operated mice; S-AL, sham-
operated ad libitum-fed mice; S-WM,
sham-operated weight-matched mice.
*P<0.05, compared with S-AL; +P<0.05,
compared with S-WM by two-factor
ANOVA. Shaded areas of graphs indicate
measurements made during the dark
phase and unshaded areas indicate
measurements made during the light
phase. Data are expressed as
mean±s.e.m.
238
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 235-243 doi:10.1242/dmm.027474
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
with S-WM along PC1 and compared with S-AL groups along PC2
(Fig. 5A; P<0.05). Rarefaction analysis revealed no significant
differences between groups in gut microbiome richness (α-
diversity). No significant differences in community structure
between groups were noted at the phylum level (Fig. 5B).
Similar to RYGB (Liou et al., 2013; Tremaroli et al., 2015), VSG
resulted in significant elevations in the relative abundance of
Gammaproteobacteria (Fig. 5C; P<0.05). Furthermore, VSG also
increased the relative abundance of Enterobacteriales and
Enterobacteriaceae, an order and family of Gammaproteobacteria,
respectively (P<0.05). Interestingly, a previous study reports that
alterations in Gammaproteobacteria are associated with central
nervous system-dependent changes in exploratory behavior in mice
(Bercik et al., 2011). Similar to our previous findings at 6.5 months
after VSG surgery in mice (McGavigan et al., 2015), the family
Enterococcaceae and genus Enterococcus were enriched in VSG
compared with S-AL and S-WM (Fig. 5D; P<0.05). Similar to
our previous findings, relative abundance of the family
Coriobacteriaceae and genus Adlercreutzia were lower in VSG
compared with S-WM (Fig. 5E; P<0.05). Interestingly, a reduction
in the abundance of Coriobacteriaceae has been reported following
RYGB in human patients (Zhang et al., 2009). Coriobacteriaceae
have been suggested to promote cholesterol absorption (Claus et al.,
2011; Martinez et al., 2009). VSG results in a body mass-
independent reduction in circulating cholesterol concentrations
(McGavigan et al., 2015). Thus, VSG-induced decreases in
Fig. 4. VSG reduces hypothalamic ER stress, hypothalamic inflammatory signaling and circulating NE concentrations. Representative immunoblots
of pPERKThr980, PERK, peIF2αSer51, eIF2α, pIRE1αSer724, IRE1α, ATF6, TNFα and tubulin (bottom) (n=3 per group). Results are quantified in densitometric units
and pPERKThr980 is expressed relative to PERK, peIF2αSer51 relative to eIF2α, pIRE1αSer724 relative to IRE1α and ATF6 and TNFα relative to tubulin (top) in
hypothalamus (A) and brainstem (B) samples collected 2.5 months after surgery (n=6 per group). (C) Fasting plasma NE at 2.5 months after surgery. VSG,
VSG-operated mice; S-AL, sham-operated ad libitum-fed mice; S-WM, sham-operated weight-matched mice. *P<0.05, compared with S-AL; +P<0.05, compared
with S-WM by Student’s t-test. Data are expressed as mean±s.e.m.
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Coriobacteriaceae levels may contribute to the decrease in
circulating cholesterol concentrations and thus improvements
in cardiometabolic health. Overall, these data demonstrate that
VSG-induced increases in Enterococcaceae, Enterococcus,
Coriobactericeae and Adlercreutzia are durable gut microbial
shifts after VSG.
DISCUSSION
Here, we provide validation of a mouse model of VSG that
recapitulates the effect of VSG to decrease AP in human
patients. Our data show that there are both body mass-dependent
and -independent mechanisms by which VSG reduces AP. This
is consistent with previous work reporting reductions in AP prior
to significant loss of body mass in humans (Ahmed et al., 2009).
Furthermore, we demonstrate a body mass-independent reduction
in hypothalamic ER stress and inflammatory signaling and body
mass-independent shifts in gut microbial populations after VSG.
Notably, this is the first rodent bariatric blood pressure study to
control for body mass, the first study to employ radiotelemetry
in a murine model of bariatric surgery and the first study to
investigate a potential role for hypothalamic ER-stress signaling
and the gut microbiome in mediating the reduction in AP after
VSG.
Critically, this study is the first to control for body mass
throughout the study, providing novel insight into the role of
body mass in the effect of VSG to decrease AP. Previous studies
have employed pair-feeding strategies to control for body mass.
However, VSG increases energy expenditure, an effect that is
present in our murine VSGmodel (McGavigan et al., 2015), making
pair-feeding insufficient for controlling for body mass. Overall, we
provide novel data showing that the VSG-induced reduction in AP is
not totally dependent on body mass.
Endocrine factors regulate AP, and elevated circulating leptin
concentrations are a common metabolic disturbance associated
with obesity that have been implicated in the pathogenesis of
hypertension (Simonds et al., 2014). Similar to previous studies, we
show that VSG surgery decreases circulating leptin concentrations
in comparison to sham-operated ad libitum-fed mice, but not
weight-matched controls, suggesting that leptin does not contribute
to the body mass-independent decreases in AP after VSG
(Cummings et al., 2012). In line with this, previous work in a
leptin receptor-deficient rat model reports reductions in AP after
VSG despite the lack of a functional leptin receptor (Rodríguez
et al., 2012b). Post-operative decreases in circulating ghrelin
concentrations have been suggested to contribute to metabolic
improvements after VSG surgery. In contrast, increased ghrelin
Fig. 5. VSG produces shifts in cecal
microbial profiles. Gut microbial
profiles were determined in cecal
content samples collected 2.5 months
after surgery. (A) Principal coordinate
analysis plots of unweighted UniFrac
distances. (B) Relative abundance of
bacterial phyla. Relative abundance
of Gammaproteobacteria (C),
Enterococcus (D), and
Adlercreutzia. (E). Relative
abundances are expressed as a
percentage of total 16S rRNA gene
sequences. VSG, VSG-operated
mice; S-AL, sham-operated ad
libitum-fed mice; S-WM, sham-
operated weight-matched mice.
*P<0.05, compared with S-AL;
+P<0.05, compared with S-WM.
Data are expressed as mean±s.e.m.
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signaling has been suggested to exert beneficial effects on AP
regulation (Nagaya et al., 2001). Therefore, our data suggest that
alterations in ghrelin do not contribute to decreased AP after VSG.
This is consistent with previous work showing that ghrelin-
knockout mice exhibit similar improvements in glucose regulation
after VSG compared with wild-type mice (Chambers et al., 2013).
Overall, post-operative reductions in circulating leptin and ghrelin
concentrations do not appear to contribute to the body mass-
independent reduction in AP after VSG surgery.
Enhanced ER stress and inflammatory signaling in the
hypothalamus are important contributors to the development of
obesity-associated hypertension (Purkayastha et al., 2011a,b). We
present novel data demonstrating a bodymass-independent decrease
in hypothalamic ER stress and inflammatory signaling after VSG,
which may contribute to post-operative decreases in AP; however,
further studies are needed to demonstrate a causal relationship.
Importantly, previous work has implicated the PERK-mediated arm
of ER-stress signaling in the pathogenesis of hypertension (Young
et al., 2012). Reductions in hypothalamic ER-stress and
inflammatory signaling contribute to reductions in AP by
reducing sympathetic outflow (Purkayastha et al., 2011a,b).
Furthermore, RYGB and VSG surgery result in decreased
sympathetic output in humans (Curry et al., 2013; Seravalle et al.,
2014). Consistent with this, we find that our murine VSG model
exhibits a body mass-independent reduction in circulating NE
concentrations. Together, our data suggest that VSG-induced
reductions in hypothalamic ER stress may decrease AP by
decreasing sympathetic output.
The mechanism(s) by which the gut microbiota regulates AP are
incompletely defined. Notably, numerous studies implicate the gut
microbiota in the pathology of neuro-immune and neuro-psychiatric
diseases, enforcing the concept of a microbiota-gut-brain axis
and suggesting that the gut microbiome can be targeted for the
treatment of diseases with a neurogenic basis (Wang and
Kasper, 2014). Specifically, there are several reports of impacts
made by the gut microbiome on metabolism and/or psychological
outcomes in rodent models that are mechanistically dependent
on interactions at the level of the brain (Cryan and Dinan, 2012;
De Vadder et al., 2014; Foster and McVey Neufeld, 2013).
Similar to our previous findings, we show that VSG surgery
enriched Gammaproteobacteria and Enterococcus populations, and
lowered Adlercreutzia populations. Adlercreutzia is a relatively
newly identified genus of the phylum Actinobacteria (family
Coriobacteriaceae). Interestingly, decreased Adlercreutzia was
recently reported to be associated with relapsing remitting
multiple sclerosis, an immune-mediated inflammatory disease of
the central nervous system (Chen et al., 2016). Further work is
required to demonstrate that the gut microbiota contribute to
improvements in AP and central nervous system homeostasis after
VSG.
In summary, we have demonstrated that VSG surgery reduces AP,
but this is only partly dependent on body mass. We provide the first
data to suggest that reductions in hypothalamic ER stress and
inflammation may contribute to decreased AP after VSG. Further
work is required to demonstrate a causal relationship between these
post-operative changes and reduced AP after VSG. Of note, there
are several other changes that occur after bariatric surgery in
humans, which are replicated in our murine VSG model and may
contribute. For example, we have previously reported increases
in circulating glucagon-like peptide-1 (GLP-1) and bile acid
concentrations in our murine VSG model and have demonstrated
that these changes contribute to the glucoregulatory benefits of
VSG (Garibay et al., 2016; McGavigan et al., 2015). Both GLP-1
and bile acids have been implicated in AP regulation and further
investigation is required to determine their role in the AP-lowering
effect of VSG (Drucker, 2016; Khurana et al., 2011). Ultimately, a
complete understanding of the mechanisms by which bariatric
surgery reduces AP will require a validated preclinical model that
recapitulates the hallmark cardiometabolic improvements observed
in humans. This work validates one such model and emphasizes the
potential drug discovery opportunities associated with future studies
in this model.
MATERIALS AND METHODS
Animals and diet
At 2 months of age, male C57BL/6J diet-induced obese micewere placed on
a 60% energy from fat high-fat diet (HFD) (D12492, Research Diets). One
week prior to surgery, mice were fasted for 6 h (08:00 h-14:00 h) and
baseline fasting tail- blood samples were collected. At 4 months of age, mice
underwent sham or VSG surgery (n=14) and were maintained on HFD
throughout the study. Sham-operated mice were divided into two groups: ad
libitum fed (S-AL) (n=11) or food restricted to match their body mass to
VSG-operated mice (S-WM) (n=12). Food intake and body mass were
measured twice per week, with the exception of S-WM animals, which
received daily rations of food in order to match their body mass to the VSG-
operated mice, as previously described (McGavigan et al., 2015). At
2.5 months after surgery, mice were fasted for 6 h (08:00 h-14:00 h) and a
fasting tail-blood sample collected prior to euthanasia by an overdose of
pentobarbital (200 mg/kg IP) for tissue collection. All animal procedures
were approved by Cornell University Institutional Animal Care and Use
Committee.
VSG surgery
VSG and sham surgery were performed as previously described
(McGavigan et al., 2015). Anesthesia was induced and maintained with
isoflurane (1.5-5%). A laparotomy incision was made and the stomach was
isolated outside the abdominal cavity. Approximately 70% of the stomach
was removed, leaving a tubular remnant. Sham surgeries were performed by
isolating the stomach and placing a simple continuous pattern of suture
extending through the gastric wall and along both gastric walls in the same
location as the VSG-operated mice.
Telemeter implantation and recordings
Immediately following either sham or VSG surgery, mice were fitted with
radiotelemetry probes (PA-C10; Data Sciences International), as
previously described (Young et al., 2012). Briefly, the radiotelemeter
catheter was implanted in the thoracic aorta via the left common carotid
artery. The body of the probe was placed in a subcutaneous pocket on the
right flank. Three light-phase recordings (10:00 h-12:00 h) were obtained
weekly during weeks 4-7 after surgery in freely moving conscious mice in
their home cages. In a subset of study mice (n=4-7), one dark-phase
recording (24:00 h-02:00 h) was obtained weekly during weeks 4-7 after
surgery.
Measurement of circulating hormones
In a subset of 5-8 mice per group, plasma leptin and ghrelin levels were
measured by sandwich electrochemiluminescence immunoassays (Meso
Scale Discovery, Gaithersburg, MA, USA).
Measurement of norepinephrine
In a subset of 7-10 mice per group, plasma NE was measured as previously
described (Jia et al., 2011; Marce et al., 1995; Nirogi et al., 2013). Briefly,
50 µl of plasma was mixed with isotopical internal standard and protein was
subsequently removed by adding 50 µl of 0.4 M perchloric acid. The clear
supernatant was mixed with 100 µl of 1 M NaHCO3 and 200 µl dansyl
chloride (1% in acetone) was added to the sample followed by heating at
65°C for 10 min. The sample was chilled on ice and dansylated
norepinephrine was extracted with 200 µl ethyl acetate. The organic phase
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was evaporated under a nitrogen stream and resuspended in acetonitrile for
UPLC-MS/MS injection. The assay was carried out on a Waters Xevo TQ
MS ACQUITY UPLC system. Dansylated norepinephrine was separated
on a Waters Acquity UPLC BEH Phenyl column (3 mm inner
diameter×100 mm with 1.7 μm particles) and detected using positive
electrospray ionization tandem mass spectrometry (ESI-MS/MS) under
optimized multiple reaction monitoring (MRM) mode. The optimized
transitions of norepinephrine and internal standard are 869.3→170.3 and
857.7→170.3, respectively.
Immunoblotting
A subset of 6 mice per group were used for assessment of hypothalamic
PERK, pPERKThr980, eIF2α, peIF2αSer55, IRE1α, pIRE1αSer724, ATF6,
TNFα and tubulin protein expression using standard methodology, as
previously described (McGavigan et al., 2015). Antibodies against PERK,
pPERKThr980 and peIF2αSer55 were from Cell Signaling (3179 and 3398,
respectively). Antibodies against eIF2α, ATF6 and tubulin were from Santa
Cruz (sc-133227, sc-22799, sc-23948, respectively) and TNFα, IRE1α and
pIRE1αSer724 antibodies were from Abcam (ab66579, ab37073, ab104157,
respectively). All antibodies were used at a concentration of 1:1000 and
pixel densities of immunoreactive bands were quantified using FluorChem
9900 (Alpha Innotech, CA).
Gut microbial analysis
Gut microbial populations were analyzed in a separate cohort of S-AL, S-WM
and VSG mice (n=6 per group). C57BL/6J mice were placed on 45% energy
from fat high-fat diet at 2 months of age andmaintained on this diet throughout
the study. Mice underwent sham or VSG surgery at 4 months of age and cecal
content samples were collected 2.5 months after surgery. Gut microbial
populations were analyzed as previously described (McGavigan et al., 2015).
Briefly, DNA was isolated from cecal contents using the MoBio PowerSoil
DNA Isolation Kit (Carlsbad, CA). The V4 region of the 16S rRNA gene was
PCR amplified using barcoded 515F and 806R primers and sequenced on an
Illumina MiSeq at the Cornell Biotechnology Resource Center Genomics
Facility. Beta-diversity was calculated using the unweighted and weighted
UniFrac metrics on an operational taxonomic unit (OTU) table rarefied to
38,000 sequences per sample (Lozupone et al., 2007). Taxonomic groups that
were differentially abundant between treatments were identified using the
Galaxy version of LEfSe (Segata et al., 2011).
Statistical analysis
Data are expressed as means±s.e.m. All statistical analyses were performed
using GraphPad Prism v.6.00. Data were analyzed using ANOVA with
Newman–Keuls post hoc analysis or by Student’s t-test, as indicated.
Differences were considered significant at P<0.05.
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